Rep. Latta, Sen. Hyde-Smith Lead Call for FDA to Immediately Restore Oversight of Chemical Abortion Pills
March 01, 2022
March 01, 2022
WASHINGTON, March 1 -- Rep. Robert E. Latta, R-Ohio, issued the following news release:
Congressman Bob Latta (R-Ohio) and U.S. Senator Cindy Hyde-Smith (R-Miss.), with 124 colleagues from the Senate and House of Representatives, this month demanded the U.S. Food and Drug Administration (FDA) immediately restore more stringent oversight of chemical abortion bills, including the in-person dispensing requirement the FDA suspended in December.
The lawmakers issued a letter . . .
Congressman Bob Latta (R-Ohio) and U.S. Senator Cindy Hyde-Smith (R-Miss.), with 124 colleagues from the Senate and House of Representatives, this month demanded the U.S. Food and Drug Administration (FDA) immediately restore more stringent oversight of chemical abortion bills, including the in-person dispensing requirement the FDA suspended in December.
The lawmakers issued a letter . . .